https://pharminent.com/strategic-news-watch-july-15-2026/ 2026-07-15T20:29:37Z Pharminent en J&J Beats Q2 Estimates, Raises Full-Year Guidance on Innovative Medicine Strength 2026-07-15T20:29:37Z Blog https://pharminent.com/jj-streamlines-pharma-supply-chain-amid-55b-us-manufacturing-push/ 2026-07-15T20:29:36Z Pharminent en J&J Streamlines Pharma Supply Chain Amid $55B US Manufacturing Push 2026-07-15T20:29:36Z Blog https://pharminent.com/manufacturing-intelligence/manufacturing-intelligence-weekly-digest-july-15-2026/ 2026-07-15T20:05:37Z Pharminent en Manufacturing Intelligence • Weekly Digest • July 15, 2026 2026-07-15T20:05:35Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-july-15-2026/ 2026-07-15T16:03:50Z Pharminent en Strategic News Watch • July 15, 2026 2026-07-15T16:03:48Z Blog https://pharminent.com/oncology/oncology-intelligence-digest-july-14-2026/ 2026-07-14T20:41:25Z Pharminent en Oncology Intelligence Digest • July 14, 2026 2026-07-14T20:41:23Z Blog https://pharminent.com/biogens-tau-targeting-alzheimers-data-show-promise-and-raise-questions/ 2026-07-14T20:34:55Z Pharminent en Biogen's Tau-Targeting Alzheimer's Data Show Promise — and Raise Questions 2026-07-14T19:54:59Z Blog https://pharminent.com/market-access/market-access-intelligence-weekly-digest-july-10-2026/ 2026-07-14T19:15:17Z Pharminent en MARKET ACCESS INTELLIGENCE • Weekly Digest • July 10, 2026 2026-07-14T19:15:15Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-july-14-2026/ 2026-07-14T15:50:07Z Pharminent en Strategic News Watch • July 14, 2026 2026-07-14T15:50:05Z Blog https://pharminent.com/biogen-data-highlight-promise-questions-surrounding-tau-targeting-alzheimers-drugs/ 2026-07-14T15:11:05Z Pharminent en Biogen data highlight promise, questions surrounding tau-targeting Alzheimer's drugs 2026-07-14T13:15:00Z Blog https://pharminent.com/spero-snaps-up-innovent-immunology-drug-in-strategic-pivot/ 2026-07-15T14:57:55Z Pharminent en Spero snaps up Innovent immunology drug in strategic pivot 2026-07-14T13:02:29Z Blog https://pharminent.com/astrazeneca-takes-another-china-trip-picking-dizals-lung-cancer-drug-for-up-to-1-5b/ 2026-07-15T14:58:45Z Pharminent en AstraZeneca takes another China trip, picking Dizal's lung cancer drug for up to $1.5B 2026-07-14T12:53:28Z Blog https://pharminent.com/novartis-and-chai-discovery-collaborate-on-antibody-identification-2/ 2026-07-14T15:12:25Z Pharminent en Novartis and Chai Discovery collaborate on antibody identification 2026-07-14T08:57:47Z Blog https://pharminent.com/fda-clears-at-home-start-dose-for-alzheimers-drug-leqembi/ 2026-07-15T14:56:22Z Pharminent en FDA clears at-home start dose for Alzheimer's drug Leqembi 2026-07-14T08:43:08Z Blog https://pharminent.com/cellares-and-sonoma-partner-to-automate-cell-therapy-manufacturing-2/ 2026-07-15T14:57:16Z Pharminent en Cellares and Sonoma partner to automate cell therapy manufacturing 2026-07-14T07:39:54Z Blog https://pharminent.com/mahzi-lets-rare-disease-families-invest-in-its-gene-therapy/ 2026-07-13T20:40:24Z Pharminent en Mahzi Lets Rare-Disease Families Invest in Its Gene Therapy 2026-07-13T20:40:24Z Blog https://pharminent.com/rare-disease-gene-therapy/rare-disease-gene-therapy-digest-july-13-2026/ 2026-07-13T20:27:29Z Pharminent en Rare Disease & Gene Therapy Digest • July 13, 2026 2026-07-13T20:27:27Z Blog https://pharminent.com/fda-posts-14-new-rejection-letters-just-days-after-confirming-a-pause/ 2026-07-13T20:32:11Z Pharminent en FDA Posts 14 New Rejection Letters Just Days After Confirming a Pause 2026-07-13T19:54:21Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-july-13-2026/ 2026-07-13T16:07:21Z Pharminent en Strategic News Watch • July 13, 2026 2026-07-13T16:07:19Z Blog https://pharminent.com/germany-approves-healthcare-costs-overhaul-despite-significant-pharma-opposition/ 2026-07-14T15:06:10Z Pharminent en Germany approves healthcare costs overhaul despite significant pharma opposition 2026-07-13T15:11:38Z Blog https://pharminent.com/major-trial-launched-to-explore-glp-1-benefit-in-dementia/ 2026-07-14T13:18:13Z Pharminent en Major trial launched to explore GLP-1 benefit in dementia 2026-07-13T13:04:52Z Blog https://pharminent.com/fda-posts-new-rejection-letters-days-after-confirming-pause/ 2026-07-14T13:18:47Z Pharminent en FDA posts new rejection letters days after confirming pause 2026-07-13T11:24:32Z Blog https://pharminent.com/hub-and-spoke-drug-manufacturing-set-to-benefit-from-new-fda-rule/ 2026-07-15T14:54:37Z Pharminent en "Hub-and-spoke" drug manufacturing set to benefit from new FDA rule 2026-07-13T10:46:16Z Blog https://pharminent.com/fda-approves-msds-keytruda-combinations-for-mibc-2/ 2026-07-13T14:59:16Z Pharminent en FDA approves MSD's Keytruda combinations for MIBC 2026-07-13T08:31:27Z Blog